A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
A&O Shearman’s life sciences team advises companies on launching and rolling out major drugs, guiding them through Belgian and EU regulatory requirements from approval and pricing to marketing, data exclusivity, procurement and compliance. The practice combines strong IP, regulatory, corporate and commercial capabilities with international reach. Co-heads Filip Van Elsen, Peter Van Dyck and Tine Carmeliet bring expertise in digital medicine, IP disputes and strategic regulatory support for pharmaceutical, biotech and medical device clients.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The Belgian A&O life sciences team stands out because of their clear understanding of our business needs, ability to distil complex legislation and regulatory processes into actionable advice and proactive attitude.’
- ‘Tine Carmeliet is a true trusted advisor when it comes to life sciences and IP matters. She inspires great confidence by providing clear and well-considered advice. She has helped us navigate through difficult cross-jurisdictional legal issues smoothly and in a cost-effective manner with the support of her international network.’
Key clients
- EQT Life Sciences
Work highlights
Advised EQT Life Sciences on a substantial minority investment – including on the key regulatory aspects - in PanTera, one of the most promising Belgian growth companies that specialises in next-generation radiopharmaceuticals.